Skip to content
Monument Therapeutics Logo Monument Therapeutics Logo
  • About
    • Leadership Team
    • Advisory Board
  • Pipeline
  • Publications
  • News
  • Contact

About matt.poulter

This author has not yet filled in any details.
So far matt.poulter has created 14 blog entries.
  • Monument Therapeutics
    Digital brain biomarker company Monument Therapeutics raises £2.6 million

Digital brain biomarker company Monument Therapeutics raises £2.6 million

By matt.poulter|2021-08-13T14:02:02+00:00July 1st, 2021|

Read More

Latent inhibition and its potential as a biomarker for schizophrenia

By matt.poulter|2021-05-21T11:57:22+00:00May 21st, 2021|

Read More
  • Monument Therapeutics
    Richard Bungay Joins the Board as a Director

Richard Bungay Joins the Board as a Director

By matt.poulter|2021-05-21T12:11:24+00:00June 29th, 2017|

Read More

Postoperative cognitive dysfunction: an acute approach for the development of novel treatments for neuroinflammation

By matt.poulter|2021-05-25T20:00:41+00:00November 2nd, 2016|

Read More
Previous12
© Copyright    |   info@monumenttx.com    |   Privacy Policy and Terms of Use   |   Website made by genapse
This website uses cookies and third party services. Ok